BML Investment Partners, L.P. 13D and 13G filings for Whitehawk Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-05 3:58 pm Unchanged | 2025-03-05 | 13D | Whitehawk Therapeutics Inc WHWK | BML Investment Partners, L.P. | 2,435,000 4.980% | 0 (Unchanged) | Filing |
| 2025-02-24 11:38 am Unchanged | 2025-02-24 | 13D | Whitehawk Therapeutics Inc WHWK | BML Investment Partners, L.P. | 2,435,000 9.900% | 0 (Unchanged) | Filing |
| 2025-02-04 11:11 am Unchanged | 2025-02-03 | 13D | Whitehawk Therapeutics Inc WHWK | BML Investment Partners, L.P. | 2,435,000 9.900% | 0 (Unchanged) | Filing |
| 2025-01-30 3:32 pm Unchanged | 2025-01-30 | 13D | Whitehawk Therapeutics Inc WHWK | BML Investment Partners, L.P. | 2,435,000 9.900% | 0 (Unchanged) | Filing |
| 2024-12-31 11:13 am Purchase | 2024-12-31 | 13D | Whitehawk Therapeutics Inc WHWK | BML Investment Partners, L.P. | 2,435,000 9.900% | 1,051,183 (+75.96%) | Filing |
| 2024-08-28 4:42 pm Purchase | 2024-08-28 | 13G | Whitehawk Therapeutics Inc WHWK | BML Investment Partners, L.P. | 1,383,817 5.600% | 1,383,817 (New Position) | Filing |